文献速递脑血管病

ASPECTS 0-5 缺血性卒中患者的机械取栓结局

Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0-5.
PubMed 文献 · Stroke · 2019-01-01

该亚组第90天良好结局率为40.1%、死亡率为40.9%;成功再灌注与良好结局、功能独立、死亡率降低及症状性颅内出血率降低独立相关。作者认为结果不足以支持普遍治疗推荐,需随机对照试验正式检验机械取栓与最佳药物治疗。

要点

  • ASPECTS 0-5患者取栓后第90天良好结局率40.1%、死亡率40.9%
  • 成功再灌注与良好结局独立相关(aOR 5.534;95%CI 2.363-12.961)
  • 成功再灌注降低死亡率(aOR 0.180;95%CI 0.083-0.390),未增加症状性颅内出血风险

核心结论

  • 在ASPECTS 0-5并接受机械取栓的患者中,成功再灌注有益且不增加症状性颅内出血风险。
  • 结果不足以支持普遍治疗推荐,需随机对照试验正式检验机械取栓与最佳药物治疗。

研究设计与样本

  • 多中心、7个机构前瞻性登记库的汇总分析(Bernese-European Registry,NCT03496064)。

主要发现

  • 该亚组第90天良好结局(mRS 0-3)率为40.1%,死亡率为40.9%。
  • 成功再灌注与良好结局独立相关(aOR 5.534;95%CI 2.363-12.961)。
  • 成功再灌注与功能独立独立相关(aOR 5.583;95%CI 1.964-15.873)。
  • 成功再灌注与死亡率降低独立相关(aOR 0.180;95%CI 0.083-0.390)。
  • 成功再灌注与症状性颅内出血率降低独立相关(aOR 0.235;95%CI 0.062-0.887)。

关键数值与推荐

  • 主要结局为第90天mRS 0-3(良好结局)。
  • 次要结局包括第90天mRS 0-2(功能独立)、第90天死亡率和症状性颅内出血发生率。
  • ASPECTS 0-4患者中死亡率降低效应仍存在(aOR 0.167;95%CI 0.056-0.499)。
  • 敏感性分析未改变主要结果。

临床怎么用

  • 对前循环大血管闭塞且ASPECTS 0-5的急性缺血性卒中患者,实现成功再灌注与更好结局相关。
  • 成功再灌注未增加症状性颅内出血风险。
  • 现有证据不足以作普遍治疗推荐,此类患者取栓决策宜个体化并考虑随机对照试验证据。
  • ASPECTS 0-4患者中成功再灌注的死亡率降低效应仍存在。

局限性

  • 为登记库汇总分析,非随机对照试验,无法排除混杂。
  • 结果不足以支持对ASPECTS 0-5患者的普遍治疗推荐。
  • 需随机对照试验正式检验机械取栓与最佳药物治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- If anterior circulation large vessel occlusion acute ischemic stroke patients presenting with ASPECTS 0-5 (Alberta Stroke Program Early CT Score) should be treated with mechanical thrombectomy remains unclear. Purpose of this study was to report on the outcome of patients with ASPECTS 0-5 treated with mechanical thrombectomy and to provide data regarding the effect of successful reperfusion on clinical outcomes and safety measures in these patients. Methods- Multicenter, pooled analysis of 7 institutional prospective registries: Bernese-European Registry for Ischemic Stroke Patients Treated Outside Current Guidelines With Neurothrombectomy Devices Using the SOLITAIRE FR With the Intention for Thrombectomy (Clinical Trial Registration-URL: https://www.clinicaltrials.gov . Unique identifier: NCT03496064). Primary outcome was defined as modified Rankin Scale 0-3 at day 90 (favorable outcome). Secondary outcomes included rates of day 90 modified Rankin Scale 0-2 (functional independence), day 90 mortality and occurrence of symptomatic intracerebral hemorrhage. Multivariable logistic regression analyses were performed to assess the association of successful reperfusion with clinical outcomes. Outputs are displayed as adjusted Odds Ratios (aOR) and 95% CI. Results- Two hundred thirty-seven of 2046 patients included in this registry presented with anterior circulation large vessel occlusion and ASPECTS 0-5. In this subgroup, the overall rates of favorable outcome and mortality at day 90 were 40.1% and 40.9%. Achieving successful reperfusion was independently associated with favorable outcome (aOR, 5.534; 95% CI, 2.363-12.961), functional independence (aOR, 5.583; 95% CI, 1.964-15.873), reduced mortality (aOR, 0.180; 95% CI, 0.083-0.390), and lower rates of symptomatic intracerebral hemorrhage (aOR, 0.235; 95% CI, 0.062-0.887). The mortality-reducing effect remained in patients with ASPECTS 0-4 (aOR, 0.167; 95% CI, 0.056-0.499). Sensitivity analyses did not change the primary results. Conclusions- In patients presenting with ASPECTS 0-5, who were treated with mechanical thrombectomy, successful reperfusion was beneficial without increasing the risk of symptomatic intracerebral hemorrhage. Although the results do not allow for general treatment recommendations, formal testing of mechanical thrombectomy versus best medical treatment in these patients in a randomized controlled trial is warranted.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kaesmacher J, Chaloulos-Iakovidis P, Panos L, et al. Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0-5. Stroke. 2019. PMID: 30827193. doi:10.1161/STROKEAHA.118.023465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。